Share ownership Orient EuroPharma Co., Ltd.

Equities

End-of-day quote Taipei Exchange Other stock markets 2026-05-08			5-day change	1st Jan Change
46.55 ^TWD	-0.11%		-3.02%	+3.91%

May. 01	Kissei Pharmaceutical Co Ltd - licensing agreement for "Olutasidenib" with Orient EuroPharma in Taiwan	RE
Mar. 11	Orient EuroPharma Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2025	CI

Aucun actionnaires trouvés: Orient EuroPharma Co., Ltd.